A phase 1, randomised, placebo-controlled, double-blind, cross-over study to evaluate systemic bioavailability of oral OTS167 under fed and fasting conditions in healthy adult subjects
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2016
At a glance
- Drugs OTS 167 (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors OncoTherapy Science
- 28 Mar 2016 New trial record
- 17 Mar 2016 Results published in OncoTherapy Sciences media release.
- 17 Mar 2016 Status changed from recruiting to completed, as reported by OncoTherapy Sciences media release.